Angiogenesis inhibitor bevacizumab increases the risk of ischemic heart disease associated with chemotherapy: a meta-analysis.

Angiogenesis inhibitor bevacizumab increases the risk of ischemic heart disease associated with chemotherapy: a meta-analysis.

Concerns have arisen regarding the risk of ischemic heart disease with the novel antiangiogenic agent bevacizumab, a recombinant humanised monoclonal antibody to the vascular endothelial growth factor that is widely used in cancer treatment. Currently, the role of bevacizumab in ischemic heart disea...

Full description

Bibliographic Details
Main Authors:	Xing-Lin Chen, Ying-Hong Lei, Cun-Fei Liu, Qun-Fang Yang, Pei-Yuan Zuo, Cheng-Yun Liu, Chang-Zhong Chen, Yu-Wei Liu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3688569?pdf=render

Similar Items

Effect of angiogenesis inhibitor bevacizumab on survival in patients with cancer: a meta-analysis of the published literature.
by: Yuan Su, et al.
Published: (2012-01-01)

Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis.
by: Pei-Yuan Zuo, et al.
Published: (2014-01-01)

Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review
by: Dongqing Guo, et al.
Published: (2018-04-01)

A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model
by: Soysal D., et al.
Published: (2014-12-01)

Neoadjuvant Bevacizumab plus Chemotherapy versus Chemotherapy Alone to Treat Non-Metastatic Breast Cancer: A Meta-Analysis of Randomised Controlled Trials.
by: Li Cao, et al.
Published: (2015-01-01)

Angiogenesis and Myogenesis in a Chronic Ischemic Heart.
by: Ibrahim, Esha
Published: (2005)

Dynamics of angiogenesis in ischemic areas of the infarcted heart
by: Koichi Kobayashi, et al.
Published: (2017-08-01)

Triplet Chemotherapy (FOLFOXIRI) Plus Bevacizumab Versus Doublet Chemotherapy (FOLFOX/FOLFIRI) Plus Bevacizumab in Conversion Therapy for Metastatic Colorectal Cancer: a Meta-Analysis
by: Lin Shui, et al.
Published: (2018-08-01)

Phase III trials of standard chemotherapy with or without bevacizumab for ovarian cancer: a meta-analysis.
by: Mingyi Zhou, et al.
Published: (2013-01-01)

A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas
by: Varun Monga, et al.
Published: (2018-02-01)

The Effect of Subconjunctival Bevacizumab on Angiogenesis in Rabbit Model
by: Nurwasis Nurwasis, et al.
Published: (2021-01-01)

Bevacizumab Inhibits Choroidal and Retinal Angiogenesis In Vitro
by: Wei-Che, Hsu, et al.
Published: (2014)

A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesis.
by: Michael I Dorrell, et al.
Published: (2021-01-01)

Tumor delivery of chemotherapy combined with inhibitors of angiogenesis and vascular targeting agents
by: Marta eCesca, et al.
Published: (2013-10-01)

Efficacy and Safety of Bevacizumab-Combined Chemotherapy for Advanced and Recurrent Endometrial Cancer: A Systematic Review and Meta-analysis
by: Hui Chen, et al.
Published: (2021-01-01)

The effects of the subconjunctival injection of bevacizumab (Avastin®) on angiogenesis in the rat cornea
by: Luiz F.M. Barros, et al.
Published: (2007-09-01)

Bevacizumab Combined with Chemotherapy for Advanced Non-small Cell Lung Cancer: A meta-analysis
by: Tao ZHANG, et al.
Published: (2013-02-01)

Effectiveness of Lomustine Combined With Bevacizumab in Glioblastoma: A Meta-Analysis
by: Xing Ren, et al.
Published: (2021-01-01)

Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups
by: Macedo Ligia, et al.
Published: (2012-03-01)

Acceptable Safety of Bevacizumab Therapy in Combination with Chemotherapy in Patients with Advanced Lung Cancer
by: Wei WU, et al.
Published: (2009-03-01)

Inflammation-Mediated Angiogenesis in Ischemic Stroke
by: Hua Zhu, et al.
Published: (2021-04-01)

Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis.
by: Irena Ilic, et al.
Published: (2016-01-01)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
by: Della Pepa C, et al.
Published: (2014-06-01)

Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery
by: Lei Zuo, et al.
Published: (2018-01-01)

Therapeutic angiogenesis of adipose-derived stem cells for ischemic diseases
by: Lina Zhao, et al.
Published: (2017-06-01)

Effectiveness and Safety of Adding Bevacizumab to Platinum-Based Chemotherapy as First-Line Treatment for Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis
by: Yi Liu, et al.
Published: (2021-06-01)

Chemotherapy plus bevacizumab as an optimal first-line therapeutic treatment for patients with right-sided metastatic colon cancer: a meta-analysis of first-line clinical trials
by: Xia-Hong You, et al.
Published: (2019-05-01)

Addition of bevacizumab to chemotherapy in advanced non-small cell lung cancer: a systematic review and meta-analysis.
by: André Bacellar Costa Lima, et al.
Published: (2011-01-01)

Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis
by: Jing Yu, et al.
Published: (2016-10-01)

Preoperative bevacizumab does not increase complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
by: Bradley H King, et al.
Published: (2020-01-01)

MicroRNA-377 regulates mesenchymal stem cell-induced angiogenesis in ischemic hearts by targeting VEGF.
by: Zhili Wen, et al.
Published: (2014-01-01)

Therapeutic Angiogenesis of PLGA-Heparin Nanoparticle in Mouse Ischemic Limb
by: Lishan Lian, et al.
Published: (2012-01-01)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer [Corrigendum]
by: Della Pepa C, et al.
Published: (2014-08-01)

The Regulatory Functions of lncRNAs on Angiogenesis Following Ischemic Stroke
by: Li Gan, et al.
Published: (2021-02-01)

Angiogenesis Biomarkers in Ischemic Stroke Patients
by: Alrafiah A, et al.
Published: (2021-09-01)

Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2-negative metastatic breast cancer: a network meta-analysis
by: Zhengwu Sun, et al.
Published: (2020-03-01)

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials
by: Russillo Michelangelo, et al.
Published: (2011-05-01)

Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials
by: Falcone Alfredo, et al.
Published: (2010-05-01)

Comparison of bevacizumab plus chemotherapy with chemotherapy alone in advanced non-small-lung cancer patients
by: Tang N, et al.
Published: (2016-07-01)

New approaches to treatment of ischemic heart disease: therapeutic angiogenesis in combination with surgical revascularization of the myocardium
by: L A Bockeria, et al.
Published: (2004-06-01)

Cannot write session to /tmp/vufind_sessions/sess_c4pqe4kju6k4vegh2dl52jtqoj